Previous Statements by OSIR
» Osiris Therapeutics, Inc. Q1 2010 Earnings Call Transcript
» Osiris Therapeutics, Inc. Q4 2008 Earnings Call Transcript
» Osiris Therapeutics, Inc. Q1 2008 Earnings Call Transcript
Trade-Ideas LLC identified Osiris Therapeutics (OSIR) as a weak on high relative volume candidate
Cramer says Osiris Therapeutics is exciting, Opko Health is a buy and you can't go wrong with PPG Industries.
Markets weren't as overheated today, Cramer says. You can buy stocks at great prices if you are patient.